# Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/olaparib-and-specific-pi3k-inhibitor-alpelisib-for-patients-with-epithelial/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Panagiotis A. Konstantinopoulos,William T. Barry,Michael J. Birrer,Shannon N. Westin,Karen A. Cadoo,Geoffrey I. Shapiro,Erica L. Mayer,Roisin E. O’Cearbhaill,Robert L. Coleman,Bose Kochupurakkal,Christin Whalen,Jennifer Curtis,Sarah Farooq,Weixiu Luo,Julia Eismann,Mary K. Buss,Carol Aghajanian,Gordon B. Mills,Sangeetha Palakurthi,Paul T. Kirschmeier,Joyce F. Liu,Lewis C. Cantley,Scott H. Kaufmann,Elizabeth M. Swisher,Alan D. D’Andrea,Eric P. Winer,Gerburg M. Wulf,Ursula A. Matulonis |
| Citations | 262 |
| DOI | 10.1016/s1470-2045(18)30905-7 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2921991537 |
| PMID | 30880072 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Robert L. Coleman](https://scholariq.org/researchers/robert-l-coleman/)
- [Roisin E. O’Cearbhaill](https://scholariq.org/researchers/roisin-e-o-cearbhaill/)
- [Carol Aghajanian](https://scholariq.org/researchers/carol-aghajanian/)
- [Elizabeth M. Swisher](https://scholariq.org/researchers/elizabeth-m-swisher/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.